Tickets are available – and registration will be open right up until the day of the event – for the 2024 Protein Science in ...

Alexander Fleming’s 1928 discovery of a mold with antibacterial properties was only the first serendipitous event on the long ...

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's ...

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced a poster presentation on HMBD-802, a novel ...

University of Melbourne researchers have developed a revolutionary 3D bioprinting technology that could transform medical ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to develop new drugs.

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today ...

Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting ...

Thinness is desirable now because it sends a signal: that one has the time to work out, the money to afford healthy foods and ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior year period. The increase in research and development expense was primarily ...

AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) platform, to be presented as a poster at the ...